Daniel Siegwart, Ph.D., is Director of the Program in Genetic Drug Engineering, Professor of Biomedical Engineering and Biochemistry, and a member of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern. [Photo: UT Southwestern]
UT Southwestern Medical Center and pharmaceutical company Pfizer have teamed up to develop new ways to deliver genetic treatments to patients.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Forget following the curve—Dallas-Fort Worth is charting its own path in artificial intelligence. From applied AI to cutting-edge research to pioneering platforms, our region is fertile ground for advancing the algorithmic age....
The University of Texas at Arlington’s commitment to sustainable, environmental research and social impact has placed it in the top quarter of global institutions according to a recent ranking.
UTA said it ranks in the top 23% globally and is ranked 77th among 239 U.S....
Using $1.8 million in federal funding, a biologist at The University of Texas at Arlington is heading up a project that could lead to improved genetic knowledge aiding in the development of synthetic therapies to prevent or treat diseases such as cancer....
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Forget following the curve—Dallas-Fort Worth is charting its own path in artificial intelligence. From applied AI to cutting-edge research to pioneering platforms, our region is fertile ground for advancing the algorithmic age....
The University of Texas at Arlington’s commitment to sustainable, environmental research and social impact has placed it in the top quarter of global institutions according to a recent ranking.
UTA said it ranks in the top 23% globally and is ranked 77th among 239 U.S....
Using $1.8 million in federal funding, a biologist at The University of Texas at Arlington is heading up a project that could lead to improved genetic knowledge aiding in the development of synthetic therapies to prevent or treat diseases such as cancer....
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.